Application Note

Enhanced T Cell Expansion And High Viability While Maintaining Early Memory Cell Phenotype

GettyImages-1168921630 drug study

The study discusses the development and performance of the Gibco™ CTS™ OpTmizer™ One Serum-Free Medium (SFM), an animal origin-free (AOF) T cell culture medium designed for T cell expansion. The medium supports robust T cell expansion and maintains high T cell viability, which is crucial for T cell therapeutics. The study compared the performance of the CTS OpTmizer One SFM with other AOF or xeno-free basal offerings, evaluating activated T cell expansion, cell viability, early memory T cell phenotypes, and CD4:CD8 ratios. The CTS OpTmizer One SFM showed comparable or higher total cell counts, greater consistency across different donors, and higher expression of early memory cell phenotype markers. The study also tested the medium with cells from healthy and diseased donors (AML and CLL), where it supported high cell expansion and viability.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online